FDA Clearance Tracker · P170042-S002
Covera Vascular Covered Stent
Last checked: Nov 20, 2026Latest source record: Mar 1, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Mar 1, 2019
Approved
Time to decision
178 days
Received Sep 4, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P170042-S002
- Device name
- Covera Vascular Covered Stent
- Applicant
- C.R. Bard, Inc.
- Applicant location
- Tempe, AZ
- Received
- Sep 4, 2018
- Decided
- Mar 1, 2019
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P170042
Device type
- Device type
- System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the COVERA Vascular Covered Stent. The device is indicated for use in hemodialysis patients for the treatment of stenoses in the venous outflow of an arterio-venous fistula and at the venous anastomosis of an ePTFE or other synthetic AV graft.
Source documents
Other decisions for C.R. Bard, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261543 · Decided Sep 28, 2026 · 143 days after receipt
Device type: Mesh, Surgical, Absorbable, Abdominal Hernia (OWT) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.